Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "020738."
| Active Ingredient: | EPROSARTAN MESYLATE |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | TEVETEN |
| Applicant: | ABBVIE |
| Strength: | EQ 400MG BASE |
| Application Number: | N020738 |
| Product Number: | 005 |
| Approval Date: | Dec 22, 1997 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | AB |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | EPROSARTAN MESYLATE |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | TEVETEN |
| Applicant: | ABBVIE |
| Strength: | EQ 600MG BASE |
| Application Number: | N020738 |
| Product Number: | 006 |
| Approval Date: | May 27, 1999 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | RX |
| TE Code: | AB |
| Patent and Exclusivity Info for this product: | View |
|
|
|
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through May, 2013 |
| Patent and Generic Drug Product Data Last Updated: June 19, 2013 |
-
